Literature DB >> 12117909

Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines.

Myron Christodoulides1, Benjamin L Makepeace, Kris A Partridge, Davindaur Kaur, Mark I Fowler, Roy O Weller, John E Heckels.   

Abstract

The interactions of Neisseria meningitidis with cells of the leptomeninges are pivotal events in the progression of bacterial leptomeningitis. An in vitro model based on the culture of human meningioma cells was used to investigate the role of the leptomeninges in the inflammatory response. Following challenge with meningococci, meningioma cells secreted specifically the proinflammatory cytokine interleukin-6 (IL-6), the CXC chemokine IL-8, the CC chemokines monocyte chemoattractant protein 1 (MCP-1) and regulated-upon-activation, normal-T-cell expressed and secreted protein (RANTES), and the cytokine growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF). A temporal pattern of cytokine production was observed, with early secretion of IL-6, IL-8, and MCP-1 followed by later increases in RANTES and GM-CSF levels. IL-6 was induced equally by the interactions of piliated and nonpiliated meningococci, whereas lipopolysaccharide (LPS) had a minimal effect, suggesting that other, possibly secreted, bacterial components were responsible. Induction of IL-8 and MCP-1 also did not require adherence of bacteria to meningeal cells, but LPS was implicated. In contrast, efficient stimulation of RANTES by intact meningococci required pilus-mediated adherence, which served to deliver increased local concentrations of LPS onto the surface of meningeal cells. Secretion of GM-CSF was induced by pilus-mediated interactions but did not involve LPS. In addition, capsule expression had a specific inhibitory effect on GM-CSF secretion, which was not observed with IL-6, IL-8, MCP-1, or RANTES. Thus, the data demonstrate that cells of the leptomeninges are not inert but are active participants in the innate host response during leptomeningitis and that there is a complex relationship between expression of meningococcal components and cytokine induction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117909      PMCID: PMC128145          DOI: 10.1128/IAI.70.8.4035-4044.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

2.  Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.

Authors:  K Geissler; M Harrington; C Srivastava; T Leemhuis; G Tricot; H E Broxmeyer
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

Review 3.  Efficacy of pneumococcal conjugate vaccines in large scale field trials.

Authors:  H R Shinefield; S Black
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

4.  C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro.

Authors:  K S Spanaus; D Nadal; H W Pfister; J Seebach; U Widmer; K Frei; S Gloor; A Fontana
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

5.  Granulocyte colony-stimulating factor in cerebrospinal fluid from patients with meningitis.

Authors:  K Shimoda; S Okamura; F Omori; Y Mizuno; T Hara; T Aoki; K Ueda; Y Niho
Journal:  Blood       Date:  1991-05-15       Impact factor: 22.113

6.  Synthesis of immunogenic oligosaccharide-protein conjugates from the lipopolysaccharide of Neisseria gonorrhoeae P9.

Authors:  P R Lambden; J E Heckels
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

7.  Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.

Authors:  Myron Christodoulides; Joy L Brooks; Elizabeth Rattue; John E Heckels
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

8.  The surface of Neisseria gonorrhoeae: isolation of the major components of the outer membrane.

Authors:  J E Heckels
Journal:  J Gen Microbiol       Date:  1977-04

9.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Compartmentalization of TNF and IL-6 in meningitis and septic shock.

Authors:  A Waage; A Halstensen; T Espevik; P Brandtzæg
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more
  19 in total

Review 1.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

Review 2.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

3.  Deciphering the contribution of human meningothelial cells to the inflammatory and antimicrobial response at the meninges.

Authors:  Pierre-Joseph Royer; Andrew J Rogers; Karl G Wooldridge; Patrick Tighe; Jafar Mahdavi; Michael G Rittig; Dlawer Ala'Aldeen
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

4.  Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis.

Authors:  Mark I Fowler; Kiave Y Ho Wang Yin; Holly E Humphries; John E Heckels; Myron Christodoulides
Journal:  Infect Immun       Date:  2006-09-05       Impact factor: 3.441

5.  Gene expression pattern in human brain endothelial cells in response to Neisseria meningitidis.

Authors:  Alexandra Schubert-Unkmeir; Olga Sokolova; Ursula Panzner; Martin Eigenthaler; Matthias Frosch
Journal:  Infect Immun       Date:  2006-11-27       Impact factor: 3.441

6.  Lipopolysaccharide up-regulates IL-6R alpha expression in cultured leptomeningeal cells via activation of ERK1/2 pathway.

Authors:  Ting Wang; Bai-Ren Wang; Hua-Zhou Zhao; Fang Kuang; Juan Fan; Xiao-Li Duan; Gong Ju
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

7.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.

Authors:  Kim Jemmett; Annalisa Macagno; Monica Molteni; John E Heckels; Carlo Rossetti; Myron Christodoulides
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

9.  Neuropeptide alpha-MSH exerts pro-inflammatory effects on Neisseria meningitidis infection in vitro.

Authors:  Pawan Kumar; Jeannette N Williams; Kesta L Durkin; John E Heckels; Peter S Friedmann; Eugene Healy; Myron Christodoulides
Journal:  Inflamm Res       Date:  2009-08-15       Impact factor: 4.575

10.  Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro.

Authors:  Khalil Alkuwaity; Alexander Taylor; John E Heckels; Kelly S Doran; Myron Christodoulides
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.